Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 20 holding rows worth $82,261,000.

Accession
0000919574-18-001462
Filed
2018-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 20 entries on the cover page, a total value of $82,261,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $82,262,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD5,514,994$39,984,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM1,013,787$10,158,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
KALA BIO INC COM483119103Stock544,220$10,063,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GARRISON CAP INC366554103COM1,000,000$8,110,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
AGILE THERAPEUTICS INC00847L100COM1,820,012$4,896,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
Berkshire Hathaway Inc084670702COM8,945$1,773,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
JBG SMITH PPTYS COM46590V100REIT41,170$1,430,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
iShares Russell 2000 ETF464287655SHS6,540$997,000thousands by filing datecallThe filing omitted confidential holdings, a later amendment may add them.
GTX INC DEL40052B207COM NEW62,869$799,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SPY78462F103SHS2,519$672,000thousands by filing dateputThe filing omitted confidential holdings, a later amendment may add them.
CM FIN INC COM12574Q103COM70,402$574,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ALCENTRA CAP CORP01374T102COM59,562$500,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ACLARIS THERAPEUTICS INC COM00461U105Stock17,994$444,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
TRIANGLE CAP CORP895848109COM40,580$385,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
INTEC PHARMA LTD JERUSALEMM53644106SHS72,782$375,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ADIENT PLCG0084W101ORD SHS4,737$373,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
FS KKR CAPITAL CORP302635107COM30,706$226,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MADRIGAL PHARMACEUTICALS INC COM558868105Stock2,418$222,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MARINUS PHARMACEUTICALS INC56854Q101COM18,643$152,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CATALYST PHARMACEUTICALS INC14888U101COM33,110$129,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-18-001462this filing2018-02-14acceptance time not in the bulk data set